Akebia Therapeutics, Inc. (AKBA) Failed to Provide Relevant Information to Keryx Shareholders in Advance of the Merger The Registration Statement issued in connection with the December 2018 merger of Keryx

CarLotz, Inc. (LOTZ, LOTZW) Made False and Misleading Statements Regarding its Busines,s Operations, and Prospects   CarLotz became a public entity via merger with Acamar Partners Acquisition Corp., a blank

Home Point Capital Inc. (HMPT) Made Misstatements in its IPO Offering Documents Home Point conducted its IPO on January 29, 2021, selling its stock at $13.00 per share for proceeds

Tarena International, Inc. (TEDU) Made Misstatements Regarding its Accounting Practices      During the class period, defendants made false and misleading statements and/or failed to disclose that: (1) certain employees were

Frequency Therapeutics, Inc. (FREQ) Misstated the Potential of its Hearing Loss Treatment FX-322   Frequency Therapeutics began its Phase 2a trial for FX-322 in October 2019.  The trial results failed

BlueCity Holdings Limited (BLCT) Misled Investors Regarding the Company’s Capability for Sustainable Growth   BlueCity conducted its IPO on July 8, 2020, issuing 5.3 million shares of the Company’s ADSs

Array Technologies, Inc. (ARRY) Failed to Disclose Rising Costs Would Have an Adverse Effect on its Business Operations Array’s Offering Materials stated that one of the Company’s strengths related to

RenovaCare, Inc. (RCAR) Had Defective Disclosure Controls and Procedures that Caused its Stock Price to be Materially Inflated   On May 28, 2021, the SEC issued a release stating it

Ebix, Inc. (EBIX) Misled Shareholders About the Adequacy of its Internal Controls Over Financial Reporting On February 19, 2021, after the market closed, Ebix revealed that its independent auditor, RSM